Dolutegravir
Composition
The formulation contains Dolutegravir 40mg Tablet: Contains dolutegravir 40mg as the active ingredient.
Indications
Treatment of HIV-1 infection in adults and children
Side effects
Headache, insomnia, gastrointestinal disturbances
Precautions
Monitor for signs of hypersensitivity reactions and neuropsychiatric symptoms.
Contraindications
Co-administration with dofetilide, Hypersensitivity to Dolutegravir or any component of the product.
Dosage and administration
50 mg once daily, adjusted based on drug interactions and renal/hepatic function
Countries
USA, UK, South Africa
Available Forms
Tablets